Market Brief

FDA Clears Sun Pharma's Halol Plant in India, an Industrial Info Market Brief

In a major decision for India's Sun Pharmaceutical Industries Limited, the U.S. Food and Drug Administration (FDA) cleared the company's export-oriented plant located in Halol in India's Gujarat state--a development that could significantly boost revenue for the Indian pharma major, as the plant alone contributes about 15% to the company's total volume of sales in the U.S. and has a share of nearly 25% in terms of profit it earns from the U.S. market. Industrial Info is tracking developments at 23 pharmaceutical plants owned by Sun Pharma globally. See map for locations.

Released Tuesday, August 20, 2019